Guidelines on the use of therapeutic apheresis in clinical practice--evidence-based approach from the Apheresis Applications Committee of the American Society for Apheresis
- PMID: 20568098
- DOI: 10.1002/jca.20240
Guidelines on the use of therapeutic apheresis in clinical practice--evidence-based approach from the Apheresis Applications Committee of the American Society for Apheresis
Abstract
The American Society for Apheresis (ASFA) Apheresis Applications Committee is charged with a review and categorization of indications for therapeutic apheresis. Beginning with the 2007 ASFA Special Issue (fourth edition), the subcommittee has incorporated systematic review and evidence-based approach in the grading and categorization of indications. This Fifth ASFA Special Issue has further improved the process of using evidence-based medicine in the recommendations by refining the category definitions and by adding a grade of recommendation based on widely accepted GRADE system. The concept of a fact sheet was introduced in the Fourth edition and is only slightly modified in this current edition. The fact sheet succinctly summarizes the evidence for the use of therapeutic apheresis. The article consists of 59 fact sheets devoted to each disease entity currently categorized by the ASFA as category I through III. Category IV indications are also listed.
Copyright 2010 American Society for Apheresis.
Similar articles
-
Guidelines on the use of therapeutic apheresis in clinical practice: evidence-based approach from the Apheresis Applications Committee of the American Society for Apheresis.J Clin Apher. 2007 Jun;22(3):106-75. doi: 10.1002/jca.20129. J Clin Apher. 2007. PMID: 17394188
-
Guidelines on the use of therapeutic apheresis in clinical practice-evidence-based approach from the Writing Committee of the American Society for Apheresis: the sixth special issue.J Clin Apher. 2013 Jul;28(3):145-284. doi: 10.1002/jca.21276. J Clin Apher. 2013. PMID: 23868759
-
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice-Evidence-Based Approach from the Writing Committee of the American Society for Apheresis: The Seventh Special Issue.J Clin Apher. 2016 Jun;31(3):149-62. doi: 10.1002/jca.21470. J Clin Apher. 2016. PMID: 27322218 Review.
-
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice - Evidence-Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue.J Clin Apher. 2019 Jun;34(3):171-354. doi: 10.1002/jca.21705. J Clin Apher. 2019. PMID: 31180581
-
Category IV indications for therapeutic apheresis: ASFA fourth special issue.J Clin Apher. 2007 Jun;22(3):176-80. doi: 10.1002/jca.20131. J Clin Apher. 2007. PMID: 17377982 Review.
Cited by
-
Evaluation of the results of the patients who underwent plasmapheresis in the pediatric intensive care unit.Turk J Med Sci. 2024 Mar 4;54(3):508-516. doi: 10.55730/1300-0144.5817. eCollection 2024. Turk J Med Sci. 2024. PMID: 39050002 Free PMC article.
-
Beneficial therapeutic plasma exchange response in the treatment of severe relapses in patients with multiple sclerosis.Acta Neurol Belg. 2024 Jul 24. doi: 10.1007/s13760-024-02606-w. Online ahead of print. Acta Neurol Belg. 2024. PMID: 39044118
-
The value of extracorporeal photopheresis as an immunosuppression-modifying approach in solid organ transplantation: a potential solution to an unmet medical need.Front Immunol. 2024 May 23;15:1371554. doi: 10.3389/fimmu.2024.1371554. eCollection 2024. Front Immunol. 2024. PMID: 38846942 Free PMC article. Review.
-
A rare case of bilateral frontal lobe lesions due to thyroid storm.Arch Endocrinol Metab. 2024 Apr 19;68:e230254. doi: 10.20945/2359-4292-2023-0254. Arch Endocrinol Metab. 2024. PMID: 38652700 Free PMC article.
-
Plasmapheresis in thyrotoxicosis: a single-center case series.J Med Case Rep. 2024 Mar 30;18(1):193. doi: 10.1186/s13256-024-04480-9. J Med Case Rep. 2024. PMID: 38553729 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
